Hypertension. 1999;33:922-923
(Hypertension. 1999;33:922-923.)
© 1999 American Heart Association, Inc.
Hypertension
The Third Five Years
Edward D. Frohlich, MD1
1 Editor-in-Chief
L. Gabriel Navar, PhD;
Richard N. Ré, MD2
2 Associate Editors
In this issue, as part of our 20th anniversary
celebration, we are pleased to honor the third editorial team that was
responsible for Hypertension from 19891993. This month we
recognize Drs Allyn L. Mark and Gerald F. DiBona, who served as
Editors-in-Chief from 1989 to 1992 and 1992 to 1993, respectively,
while they shared editorial responsibilities at the University of Iowa
College of Medicine in Iowa City. They were ably supported by Drs
Francois M. Abboud, Donald D. Heistad, and Larry S. Tobacman during
this five-year period. Dr DiBona also supported Dr Mark during Dr
Mark's term. It was during their tenure that the journal became
established as a major scientific journal even though it met with
increasing competition from no fewer than seven other hypertension
journals. Despite this auspicious competition, Hypertension
endured, and we are grateful to this team from Iowa for maintaining the
journal's position and esteem as viewed by investigators the world
over.
Once again, we have identified the top 25 manuscripts according to
their frequency of citation in the world scientific literature.
However, 26 references are included since the 25th and 26th papers were
tied in the number of citations. We again emphasize that these papers
are listed alphabetically according to the last name of the first
author. These papers are as follows:
- Anderson EA, Mark AL. The vasodilator action of insulin:
implications for the insulin hypothesis of hypertension.
Hypertension. 1993;21:136141.
- Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal
muscle blood flow: a possible link between insulin resistance and blood
pressure. Hypertension. 1993;21:129135.
- Berk BC, Vekshtein V, Gordon HM, Tsuda T.
Angiotensin II-stimulated protein synthesis in cultured
vascular smooth muscle cells. Hypertension. 1989;
13:305314.
- Buga GM, Gold ME, Fukuto JM, Ignarro LG. Shear stress-induced
release of nitric oxide from endothelial cells grown on
beads. Hypertension. 1991; 17:187193.
- Bumpus FM, Catt KJ, Chiu AT, DeGasparo M, Goodfriend T,
Husain A, Peach MJ, Taylor DG Jr, Timmermans PB. Nomenclature for
angiotensin receptors: a report of the Nomenclature
Committee of the Council for High Blood Pressure Research.
Hypertension. 1991;17:720721.
- Chobanian AV, Haudenschild CC, Nickerson C, Drago R.
Antiatherogenic effects of captopril in the Watanabe heritable
hyperlipidemic rabbit. Hypertension.
1990;15:327331.
- Clozel M, Kuhn H, Hefti F. Effects of angiotensin
converting enzyme inhibitors and of hydralazine on
endothelial function in hypertensive rats.
Hypertension. 1990;16:532540.
- Dzau VJ, Gibbons GH, Pratt RE. Molecular mechanisms of
vascular renin-angiotensin system in myointimal
hyperplasia. Hypertension. 1991;18(suppl
4)II-100II-105.
- Erdos EG. Angiotensin I converting enzyme and the
changes in our concepts through the years: Lewis K. Dahl Memorial
Lecture. Hypertension. 1990; 16:363370.
- Gardiner SM, Compton AM, Bennett T, Palmer RM, Moncada S.
Control of regional blood flow by endothelium-derived
nitric oxide. Hypertension. 1990; 15:486492.
- Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG,
Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes
vascular hypertrophy in part by a non-pressor mechanism.
Hypertension. 1991; 17:626635.
- Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever
AF. Brief angiotensin converting enzyme
inhibitor treatment in young spontaneously hypertensive
rats reduces blood pressure long-term. Hypertension.
1990;16:603614.
- Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ.
Small artery structure in hypertension: Dual processes of remodeling
and growth. Hypertension. 1993;21:391397.
- Ignarro LJ. Nitric Oxide: A novel signal transduction
mechanism for transcellular communication. Hypertension.
1990;16:477483.
- Janiak P, Pillon A, Prost JF, Vilaine JP. Role of
angiotensin subtype 2 receptor in neointima
formation after vascular injury. Hypertension. 1992;
20:737745.
- Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P,
Floege J, Schwartz SM. Renal injury from angiotensin
II-mediated hypertension. Hypertension.
1992;20:298303.
- Kato T, Iwama Y, Okumura K, Hashimoto H, Ito T, Satake T.
Prostaglandin H2 may be the
endothelium-derived contracting factor released by
acetylcholine in the aorta of the rat. Hypertension. 1990;
15:475481.
- Luscher TF, Boulanger CM, Dohi Y, Yang ZH.
Endothelium-derived contracting factors.
Hypertension. 1992;19:117130.
- O'Rourke M. Arterial stiffness, systolic
blood pressure, and logical treatment of arterial
hypertension. Hypertension. 1990;15:339347.
- Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G.
Comparison of finger and intra-arterial blood pressure
monitoring at rest and during laboratory testing.
Hypertension. 1989;13(pt 1):647655.
- Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R.
Chronic inhibition of nitric oxide synthesis: A new model of
arterial hypertension. Hypertension.
1992;20:298303.
- Schichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S,
Ogura M, Inoue A, Marumo F. Plasma endothelin levels in hypertension
and chronic renal failure. Hypertension.
1990;15:493496.
- Vanhoutte PM. Endothelium and control of
vascular function. State of the Art Lecture. Hypertension.
1989;13(pt 2):658667.
- Wiemer G, Schölkens BA, Becker RH, Busse R.
Ramiprilat enhances endothelial autacoid
formation by inhibiting breakdown of
endothelium-derived bradykinin.
Hypertension. 1991;18:558563.
- Wong PC, Price WA Jr, Chiu AT, Carini DJ, Duncia JV, Johnson
AL, Wexler RR, Timmermans PB. Nonpeptide angiotensin II
receptor antagonists: Studies with EXP9270 and DuP 753.
Hypertension. 1990;15(pt 2):823834.
- Wong PC, Price WA Jr, Chiu AT, Duncia JV, Carini DJ, Wexler
RR, Johnson AL, Timmermans PB. Hypotensive action of DuP 753, an
angiotensin II antagonist, in spontaneously
hypertensive rats: Nonpeptide angiotensin II receptor
antagonists; X. Hypertension.
1990;15:459468.